Riferimento farmaci
Atrasentan
Atrasentan is a medicine in the class miscellaneous. It is used for nephropathy.
- Classe del farmaco: Miscellaneous
- Indicato per: nephropathy
Ultimo aggiornamento Fonti: US FDA label
Per operatori sanitari — solo a scopo di riferimento. Questa pagina è una sintesi breve, non è un parere medico e non sostituisce il RCP ufficiale né il giudizio clinico. Verificare sempre prima di prescrivere o dispensare.
Il contenuto clinico di questa pagina è disponibile solo in inglese.
In breve
- Classe del farmaco
- Miscellaneous
- Forme farmaceutiche comuni
- compressa
- Dosaggi comuni
- 0.75 mg
- Nomi commerciali
- 1
- Paesi e mercati
- 1
Per cosa si usa
Come agisce
Atrasentan is an endothelin type A (ET A) receptor antagonist with >1800-fold selectivity for ET A over the endothelin type B receptor. Endothelin-1 is thought to contribute to IgAN pathogenesis via the ET A receptor.
Dose abituale nell'adulto (sintesi del foglio illustrativo)
Reduction of proteinuria in primary IgAN: 0.75 mg orally once daily with or without food.
Gravidanza e allattamento
- Gravidanza
- Unsafe Contraindicated; animal studies show teratogenicity and fetal harm including birth defects and fetal death.
- Allattamento
- Unsafe No human milk data; advise not to breastfeed during treatment because of potential adverse reactions such as fluid retention in infants.
Effetti indesiderati segnalati
- Peripheral edema
- Anemia
- Liver transaminase elevation
Avvertenze in evidenza
- Embryo-fetal toxicity: contraindicated in pregnancy; may cause major birth defects based on animal data. Exclude pregnancy before starting. Use effective contraception before, during, and for two weeks after treatment. Stop as soon as possible if pregnancy occurs.
Controindicazioni
- Pregnancy.
- History of hypersensitivity reaction to atrasentan or any component of the product.
Chi deve prestare attenzione
- Embryo-fetal toxicity: may cause fetal harm; exclude pregnancy before starting and use effective contraception.
- Hepatotoxicity: obtain liver enzymes before starting and as clinically indicated; do not initiate in severe hepatic impairment; discontinue if clinically relevant aminotransferase elevations occur.
- Fluid retention: not evaluated in IgAN patients with heart failure; if significant, consider diuretic and interrupting treatment.
Informare il farmacista o il medico di gravidanza o allattamento, malattie renali o epatiche, allergie e di ogni altro farmaco o integratore assunto.
Per gli utenti Pro+
Sblocca la pagina completa
Crei un account e avvii una prova di Pro+ per aprire la monografia completa di Atrasentan: dosi, gravidanza e allattamento, effetti indesiderati, avvertenze e tutte le interazioni.
- Dosing by age, kidney and liver function, and further dose lines
- Renal and hepatic dose adjustments
- How to give it
- Pharmacokinetics
- Patient counselling points
- Food interactions
Provi Pro+ gratis per 14 giorni sul web. Nessuna carta.
Domande frequenti
What is Atrasentan used for?
Atrasentan is a medicine in the class miscellaneous. It is used for Nephropathy.
What side effects have been reported with Atrasentan?
Peripheral edema, Anemia, Liver transaminase elevation. Serious warning: Embryo-fetal toxicity: contraindicated in pregnancy; may cause major birth defects based on animal data.
Can Atrasentan be taken in pregnancy or while breastfeeding?
Pregnancy: Unsafe. Contraindicated; animal studies show teratogenicity and fetal harm including birth defects and fetal death. Breastfeeding: Unsafe. No human milk data; advise not to breastfeed during treatment because of potential adverse reactions such as fluid retention in infants.
What does Atrasentan interact with?
MediHelp does not list a checked interaction for Atrasentan yet. Always tell your pharmacist about every medicine you take.
Monografie complete, posologie e verifica delle interazioni nell'app MediHelp
Apra il riferimento completo, verifichi le interazioni tra più farmaci e usi gli strumenti di posologia nell'app MediHelp.
